Contact us contattaci
logo
logo

About Us

Home / The Group / About Us

The CDMO that grows by innovating

Biofarma Group is the new global market leader in developing, producing, and packaging food supplements, medical devices, probiotic-based drugs, and cosmetics exclusively for third parties. With a turnover of around 436 million euros and over 1500 employees, Biofarma Group is already a focal point in the Health-Care sector in the Italian and European markets.

The choice of subcontracting responds to a highly specialised strategic focus: the business model developed has allowed a global approach to market, product and customer service innovation needs, which has meant being able to take care of the entire process, from research and development, product design, industrialisation, production, regulatory and quality standards and certification, to packaging and logistics, entirely on behalf of partners.

Biofarma Group: figures that continue to grow
436
million Euros in sales
500
clients
2000
products
192
patents
1500
employees
8
manufacturing sites in Europe, USA and China
7
R&D labs
1
global nutraceutical player

Innovation, production excellence, and the high professionalism of the team are the values at the base of this new industrial project. The skills that make up each company of the Group. Eight production sites distributed between Europe, USA and China, allow us to offer customized solutions and an even more complete and transversal service ranging from the development of the idea to the finished product, as well as a vast catalogue of products, including dossiers, some of which are patented, available in out-licensing for customers with the possibility of being marketed all over the world.

Il Board

Gianfranco Nazzi – CEO

Germano Scarpa – Chairman

logo
© Biofarma Srl C.F. and P.IVA 02895910301
T. +39 0432 868711 F. +39 0432 868018
Via Castelliere, 2
33036 Mereto di Tomba (UD) Italy
Number REA UD - 296214
Date of entry in the
Business Register of UDINE: 01/07/2017
Registration number: 02895910301
Share capital euro 3.000.000